Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis-Reference-Cited by-同舟云学术

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

Published:2006-03-02 Issue:9 Volume:354 Page:911-923
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Rudick Richard A.,Stuart William H.,Calabresi Peter A.,Confavreux Christian,Galetta Steven L.,Radue Ernst-Wilhelm,Lublin Fred D.,Weinstock-Guttman Bianca,Wynn Daniel R.,Lynn Frances,Panzara Michael A.,Sandrock Alfred W.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa044396

Cited by 1147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy of subcutaneous versus intravenous natalizumab on annualized relapse rate: A post-hoc analysis of the REFINE study;Multiple Sclerosis and Related Disorders;2024-11

2. Literature review and meta-analysis of natalizumab therapy for the treatment of highly active relapsing remitting multiple sclerosis in the ‘suboptimal therapy’ patient population;Journal of the Neurological Sciences;2024-09

3. Frequent detection of IFN-gamma -producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathy;Frontiers in Immunology;2024-07-17

4. NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab;Multiple Sclerosis and Related Disorders;2024-07

5. Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?;Current Neuropharmacology;2024-07